Clinical Trial Update: Evaluate Low Doses of AEGR-733 on Hepatic Fat Accumulation by MRS [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating low doses of AEGR-733 for reducing hepatic fat accumulation in patients with hyperlipidemia; the study is completed with res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• AEGR-733

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Hyperlipidemia | Phase 2 | Status: COMPLETED | Results posted: 2013-02-22